Friday, March 6, 2015



Soy un nuevo usuario

Olvidé mi contraseña

Entrada usuarios

Lógica Matemáticas Astronomía y Astrofísica Física Química Ciencias de la Vida
Ciencias de la Tierra y Espacio Ciencias Agrarias Ciencias Médicas Ciencias Tecnológicas Antropología Demografía
Ciencias Económicas Geografía Historia Ciencias Jurídicas y Derecho Lingüística Pedagogía
Ciencia Política Psicología Artes y Letras Sociología Ética Filosofía

A Small-Molecule p53 Activator Induces Apoptosis through Inhibiting MDMX Expression in Breast Cancer Cells12

1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario
    registrado en Universia

  Descargar recurso

Detalles del recurso

Pertenece a: PubMed Central (PMC3 - NLM DTD)  

Descripción: The tumor suppressor p53 is often inactivated in breast cancer cells because the overexpression of its repressors (e.g., MDM2 and MDMX). Restoration of p53 activity by small molecules through counteracting p53 repressors can lead to in vivo tumor regression and is therefore considered a promising strategy for treatments of cancer. Recent efforts in high-throughput drug screening and rational drug design have identified several structurally diverse small-molecule p53 activators, including a pseudourea derivative XI-011 (NSC146109). This small molecule strongly activates p53 while selectively inhibiting growth of transformed cells without inducing genotoxicity, indicating its potential as a drug lead for p53-targeted therapy. However, the mechanism(s) by which XI-011 activates p53 and the effects of XI-011 on growth of breast cancer cells are currently unknown. Here, we report that XI-011 promoted breast cancer cells to undergo apoptosis through activating p53 and inducing expression of proapoptotic genes. Importantly, we found that activation of p53 by this small molecule was achieved through a novel mechanism, that is, inhibition of MDMX expression. XI-011 repressed the MDMX promoter, resulting in down-regulation of MDMX messenger RNA level in MCF-7 cells. In line with these results, XI-011 decreased the viability of breast cancer cells expressing low levels of MDMX in a less-efficient manner. Interestingly, XI-011 acted additively with the MDM2 antagonist Nutlin-3a to inhibit growth of breast cancer cells. We conclude that XI-011 belongs to a novel class of small-molecule p53 activators that target MDMX and could be of value in treating breast cancer.

Autor(es): Wang, Hongbo -  Yan, Chunhong - 

Id.: 54060131

Idioma: English  - 

Versión: 1.0

Estado: Final

Palabras claveResearch Article - 

Tipo de recurso: Text  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

Requerimientos técnicos:  Browser: Any - 

Fecha de contribución: 01-ago-2011



Otros recursos del mismo autor(es)

  1. A novel refinement approach for text categorization In this paper we present a novel strategy, DragPushing, for improving the performance of text classi...
  2. $rec.titulo doi:10.1093/carcin/bgn007
  3. Mutation analysis of the FOXL2 gene in Chinese patients with blepharophimosisptosis-epicanthus inversus syndrome. Mutagenesis 2006; 21:35 Blepharophimosis–ptosis–epicanthus inversus syndrome (BPES) is an autosomal dominant disorder charac...
  4. EZ-Sketching: Three-Level Optimization for Error-Tolerant Image Tracing b c e fd Figure 1: The proposed system automatically refines sketch lines (a, c, e) (created by diff...
  5. Aggregate Human Mobility Modeling Using Principal Component Analysis∗ Accurate modeling of aggregate human mobility benefits many aspects of cellular mobile net-works. Co...

Otros recursos de la misma colección

  1. Amino Acid Deprivation Promotes Tumor Angiogenesis through the GCN2/ATF4 Pathway1 As tumors continue to grow and exceed their blood supply, nutrients become limited leading to defici...
  2. The N550K/H Mutations in FGFR2 Confer Differential Resistance to PD173074, Dovitinib, and Ponatinib ATP-Competitive Inhibitors12 We sought to identify fibroblast growth factor receptor 2 (FGFR2) kinase domain mutations that confe...
  3. p53-stabilizing Agent CP-31398 Prevents Growth and Invasion of Urothelial Cancer of the Bladder in Transgenic UPII-SV40T Mice12 The high prevalence of bladder cancer and its recurrence make it an important target for chemopreven...
  4. A Novel PTEN/Mutant p53/c-Myc/Bcl-XL Axis Mediates Context-Dependent Oncogenic Effects of PTEN with Implications for Cancer Prognosis and Therapy12 Phosphatase and tensin homolog located on chromosome 10 (PTEN) is one of the most frequently mutated...
  5. Flavopiridol Synergizes with Sorafenib to Induce Cytotoxicity and Potentiate Antitumorigenic Activity in EGFR/HER-2 and Mutant RAS/RAF Breast Cancer Model Systems12 Oncogenic receptor tyrosine kinase (RTK) signaling through the Ras-Raf-Mek-Erk (Ras-MAPK) pathway is...

Valoración de los usuarios

No hay ninguna valoración para este recurso.Sea el primero en valorar este recurso.

Busque un recurso